Jackie Hua

Jackie Hua is a Portfolio Manager at Walleye Capital in New York, where she leads investment strategies with a primary focus on innovative medicine and therapeutic sectors, particularly within biotechnology and healthcare. She is recognized for managing significant portfolios, reportedly directing approximately $300 million in strategies centered around emerging biotech and life sciences companies.

Before joining Walleye Capital in October 2021, Jackie Hua served as a Portfolio Manager at Maven Securities and as an Analyst at Surveyor Capital, where she built a reputation for specialized healthcare and therapeutic investments. Her expertise spans both public equities and clinical-stage biopharmaceutical investments, with an approach grounded in deep fundamental research and sector-specific analysis.

Jackie holds academic credentials from both Peking University and Stanford University, supporting her rigorous analytical framework and domain expertise in healthcare investing. She is considered a notable portfolio manager in the biotech space, with a proven track record of identifying high-conviction opportunities in the rapidly evolving landscape of medicine and therapeutics.